ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CERT Certara Inc

17,60
-0,01 (-0,06%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Certara Inc CERT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,06% 17,60 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
17,93 17,45 17,94 17,60 17,61
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202414:00GLOBECertara Launches Cloud Platform to Further Unify its..
09.4.202422:15GLOBECertara to Report First Quarter 2024 Financial Results on..
06.3.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:26EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202422:21EDGAR2Form 8-K - Current report
29.2.202422:10GLOBECertara Reports Fourth Quarter 2023 Financial Results
21.2.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202418:25EDGAR2Form 144 - Report of proposed sale of securities
14.2.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202423:14EDGAR2Form 144 - Report of proposed sale of securities
01.2.202422:30GLOBECertara to Report Fourth Quarter and Full Year 2023..
28.12.202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202318:22EDGAR2Form 144 - Report of proposed sale of securities
13.12.202322:30GLOBECertara Acquires Applied BioMath Expanding Its Biosimulation..
21.11.202322:30GLOBECertara introduces Simcyp™ Biopharmaceutics software to..
08.11.202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:16EDGAR2Form 8-K - Current report
08.11.202322:10GLOBECertara Reports Third Quarter 2023 Financial Results
11.10.202322:15GLOBECertara to Report Third Quarter 2023 Financial Results on..
06.10.202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.9.202314:15GLOBECertara Announces 300th Regulatory Submission Milestone..
29.8.202322:15GLOBECertara to Participate in Upcoming Investor Conferences
29.8.202314:15GLOBECertara Simcyp™ Group Awarded Two New Grants from US FDA
09.8.202322:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:15GLOBECertara Reports Second Quarter 2023 Financial Results
09.8.202322:11EDGAR2Form 8-K - Current report
04.8.202303:00BWCertara collaborates with Korea Institute of Toxicology to..
02.8.202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.7.202322:30GLOBECertara to Report Second Quarter 2023 Financial Results on..
03.7.202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.6.202322:15GLOBECertara to Participate in the Jefferies Global Healthcare..
08.5.202322:15GLOBECertara Reports First Quarter 2023 Financial Results

Kürzlich von Ihnen besucht

Delayed Upgrade Clock